Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts
Authors:
- 7 June 2005
- journal article
- clinical trial
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 112 (8) , 1121-1125
Abstract
Objective To compare the efficacy and tolerability of the levonorgestrel intrauterine system (LNG IUS) with mefenamic acid in the management of objective idiopathic menorrhagia.Design Phase III, Single centre, open, randomised, comparative, parallel group study.Setting District General Hospital in the United Kingdom.Population Fifty‐one women with objective menorrhagia.Methods Twenty‐five women randomised to receive the LNG IUS and 26 to oral mefenamic acid for six cycles.Main outcome measures Change from baseline in menstrual blood loss (MBL), total menstrual fluid loss (TMFL) and pictorial blood loss assessment chart (PBAC) score at the third and sixth cycle of treatment.Results After six cycles the median menstrual blood loss was 5 mL in the LNG IUS group and 100 mL in the mefenamic acid group (P < 0.001). Median TMFL was 27 mL in the LNG IUS group and 157 mL in the mefenamic acid group (P < 0.001). Median PBAC score was 25 in the LNG IUS group and 159 in the mefenamic acid group. Changes in menstrual blood loss correlated strongly to changes in TMFL (r= 0.88) but PBAC correlated less well to blood loss and total fluid loss (r= 0.53 and r= 0.58).Conclusions Both the LNG IUS and mefenamic acid significantly decreased menstrual blood loss, TMFL and PBAC scores. The LNG IUS produced greater reductions in all parameters than mefenamic acid. Comparison of the different measurements suggests that TMFL assessment may be an easier and a more relevant measure of symptom severity than menstrual blood loss.Keywords
This publication has 22 references indexed in Scilit:
- Estimating menstrual blood loss in women with normal and excessive menstrual fluid volume1Obstetrics & Gynecology, 2001
- The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systematic reviewBritish Journal of Obstetrics and Gynaecology, 2001
- Two‐year follow up of women randomised to medical management or transcervical resection of the endometrium for heavy menstrual loss: clinical and quality of life outcomesBJOG: An International Journal of Obstetrics & Gynaecology, 1999
- Randomised comparative trial of the intrauterine system and norethisterone levonor gestrel for treatment of idiopathic menorrhagiaBJOG: An International Journal of Obstetrics & Gynaecology, 1998
- A randomized study comparing levonorgestrel intrauterine system (LNG IUS) and transcervical resection of the endometrium (TCRE) in the treatment of menorrhagia: preliminary resultsGynaecological Endoscopy, 1998
- Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleedingObstetrics & Gynecology, 1997
- The levonorgestrel intrauterine system in the management of menorrhagiaBJOG: An International Journal of Obstetrics & Gynaecology, 1997
- Treating Menorrhagia in Primary Care: An Overview of Drug Trials and a Survey of Prescribing PracticeInternational Journal of Technology Assessment in Health Care, 1995
- Outcomes of referrals to gynaecology outpatient clinics for menstrual problems: an audit of general practice recordsBJOG: An International Journal of Obstetrics & Gynaecology, 1991
- Assessment of menstrual blood loss using a pictorial chartBJOG: An International Journal of Obstetrics & Gynaecology, 1990